Connection
Craig Jordan to CD4-Positive T-Lymphocytes
This is a "connection" page, showing publications Craig Jordan has written about CD4-Positive T-Lymphocytes.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.039 |
|
|
|
-
Lee-Sherick AB, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS, Hill AA, Wang X, Frye SV, Earp HS, Jordan CT, DeRyckere D, Graham DK. MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. JCI Insight. 2018 11 02; 3(21).
Score: 0.024
-
Mofenson LM, Moye J, Bethel J, Hirschhorn R, Jordan C, Nugent R. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. JAMA. 1992 Jul 22-29; 268(4):483-8.
Score: 0.015